Let’s get the word out about meningitis B
We send our kids out into the world, full of hope.
And we don't want something like meningitis B getting in their way.
Not an actual group.
For illustrative purposes only.
BEXSERO is an FDA-approved vaccine to prevent invasive disease caused by Neisseria meningitidis serogroup B. BEXSERO is approved for use in individuals aged 10 through 25 years.
Approval of BEXSERO is based on demonstration of immune response against three serogroup B strains representative of prevalent strains in the United States. The effectiveness of BEXSERO against diverse serogroup B strains has not been confirmed.
BEXSERO may not protect all individuals.
BEXSERO is the ONLY
meningitis B vaccine
that can
be completed in as fast as
1 month with just 2 doses
Help protect your teen against meningitis B.
Talk to your healthcare professional about vaccination with BEXSERO.
FIND OUT WHERE TO GET BEXSERO
More than 80% of 17-year-olds in the US
had not received any meningitis B vaccines as of 2018
The meningitis vaccine people may have received when they were younger covered meningitis ACWY, not meningitis B. That's because a meningitis B vaccine wasn't available until 2014.
BEXSERO is a vaccine approved to help prevent meningitis B.
Although meningitis B is uncommon,
it's not a chance you want to take
Increased
rates.
16- to 23-year-olds
have increased rates
of meningitis B
Uncommon but can be fatal.
About 10-15 out of 100 people infected with meningitis B will die, sometimes within 24 hours
Sudden & unpredictable.
Meningitis B strikes quickly - usually without warning
MORE ABOUT MENINGITIS B
Need reminders for the second dose of BEXSERO?
It’s important to get both doses of BEXSERO. Sign up for GSK’s 2nd Dose Reminder Service for Meningitis B.
You’ll get text message reminders to help you remember to schedule your next appointment and get the 2nd dose.
GET 2nd DOSE REMINDERS